TriMetis
TriMetis is a preclinical services company specializing in digital pathology and AI-driven solutions. They provide a comprehensive suite of services including biospecimen procurement, digital image management, and laboratory automation, aimed at enhancing research efficiency for medical device, pharmaceutical, and biotech companies. Their innovative machine learning applications streamline the identification of tumor tissue regions, significantly improving throughput for NextGen Sequencing. With a focus on quality and automation, TriMetis positions itself as a leader in the digital pathology market, catering to the needs of researchers and institutions.
TriMetis
TriMetis is a preclinical services company specializing in digital pathology and AI-driven solutions. They provide a comprehensive suite of services including biospecimen procurement, digital image management, and laboratory automation, aimed at enhancing research efficiency for medical device, pharmaceutical, and biotech companies. Their innovative machine learning applications streamline the identification of tumor tissue regions, significantly improving throughput for NextGen Sequencing. With a focus on quality and automation, TriMetis positions itself as a leader in the digital pathology market, catering to the needs of researchers and institutions.
TL;DR
Founded: 2011
Headquarters: Memphis, Tennessee, United States
Sector: Preclinical services / Digital pathology
Notable tech: Machine-learning workflow for tumor region identification
Last disclosed funding: Seed (Jun 23, 2014)
Company Overview
Problem Domain
Preclinical research efficiency and digital pathology for oncology workflows.
Founded
2011
Industry
Biotechnology
Tech Stack
Funding Track Record
Last disclosed funding round date per public profiles; total funding amounts are obfuscated in sources.